Bedford, MA, United States of America

Thia Baboval St Martin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Thia Baboval St Martin

Introduction

Thia Baboval St Martin is a prominent inventor based in Bedford, MA, known for his groundbreaking contributions to the field of genetic medicine. He has a particular focus on developing innovative solutions to restore gene function, showcasing his commitment to advancing healthcare through scientific discovery.

Latest Patents

St Martin holds one patent titled "Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof." This patent details recombinant adeno-associated virus (rAAV) compositions that have the potential to restore phenylalanine hydroxylase (PAH) gene function in cells. The techniques described are aimed at treating diseases associated with reduced PAH gene function, such as phenylketonuria (PKU). Additionally, the patent covers nucleic acids, vectors, packaging systems, and methodologies for producing these adeno-associated virus compositions.

Career Highlights

Throughout his career, Thia Baboval St Martin has worked with Homology Medicines, Inc., a company dedicated to pioneering gene editing and gene therapy technologies. His work at the company emphasizes his role in pushing the boundaries of genetic research and its applications in practical medicine.

Collaborations

St Martin collaborates with notable colleagues, including Jason Boke Wright and Danielle Lauren Sookiasian. Their combined efforts contribute to the innovative research environment at Homology Medicines, Inc., fostering advancements in the field of gene therapy.

Conclusion

Thia Baboval St Martin exemplifies the spirit of innovation and dedication to improving human health through science. His patent and collaborative work at Homology Medicines, Inc. highlight his significant contributions to medical research, aiming to address serious genetic disorders effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…